Skip to main content

Table 1 Clinical and demographic characteristics of the study population

From: A novel clinical diagnostic marker predicting the relationship between visceral adiposity and renal function evaluated by estimated glomerular filtration rate (eGFR) in the Chinese physical examination population

Variables

90 ≤ eGFR ≤ 120

eGFR < 90

P value

Age (years)

48.0 (42.0,54.0)

57.0 (51.0,63.0)

< 0.001

Sex

  

< 0.001

 Male

2074 (59.3)

1382 (74.4)

 

 Female

1423 (40.7)

476 (25.6)

 

Height (cm)

165.5 (159.5171.0)

167.0 (161.0,171.5)

< 0.001

Weight (kg)

65.9 (57.6,74.4)

69.1 (61.3,77.4)

< 0.001

BMI (kg/m2)

24.0 (21.9,26.2)

25.0 (22.9,27.0)

< 0.001

Pulse

76 (69,83)

75 (68,83)

< 0.001

DBP (mmHg)

70 (62.,78)

72 (64,80)

< 0.001

SBP (mmHg)

119 (108,131)

126 (114,137)

< 0.001

FPG (mmol/L)

4.83 (4.52,5.25)

4.93 (4.60,5.39)

< 0.001

Hemoglobin(g/L)

146.00 (135.00,157.00)

149.00 (139.00,159.00)

< 0.001

HbA1c, %

5.60 (5.40,5.90)

5.80 (5.50,6.10)

< 0.001

TC (mmol/L)

5.11 (4.50,5.77)

5.16 (4.51,5.88)

0.201

TG (mmol/L)

1.30 (0.90,1.93)

1.44 (1.04,2.07)

< 0.001

HDL (mmol/L)

1.29 (1.11,1.50)

1.22 (1.06,1.41)

< 0.001

LDL (mmol/L)

2.73 (2.26,3.22)

2.84 (2.37,3.33)

< 0.001

Hs-CRP (mg/L)

0.80 (0.40,1.40)

1.00 (0.50,1.90)

< 0.001

UA (μmol/L)

327.00 (269.00,390.00)

368.00 (313.00,427.00)

< 0.001

BUN (mmol/L)

4.75 (4.08,5.52)

5.28 (4.58,6.04)

< 0.001

SG

1.02 (1.02,1.03)

1.02 (1.02,1.02)

< 0.001

CA211(ug/ml)

1.50 (1.00,2.00)

1.70 (1.20,2.40)

< 0.001

CEA (ng/ml)

1.70 (1.10,2.50)

2.10 (1.40,3.00)

< 0.001

SCC (ug/L)

0.80 (0.60,1.00)

0.90 (0.70,1.10)

< 0.001

Albumin(g/L)

42.50 (40.70,44.10)

42.00 (40.40,43.50)

< 0.001

TT3(ng/ml)

1.48 (1.34,1.63)

1.54 (1.40,1.69)

< 0.001

WC (cm)

83.0 (76.0,89.0)

87.0 (81.0,93.0)

< 0.001

LAP

27.06 (15.10,45.24)

33.89 (20.74,53.20)

< 0.001

CVAI

92.77 (62.50,122.02)

115.72 (88.96,140.25)

< 0.001

VAI

1.46 (0.96,2.31)

1.65 (1.09,2.53)

< 0.001

WHR

0.90 (0.85,0.94)

0.93 (0.89,0.97)

< 0.001

  1. Control: 90 ≤ eGFR≤120 mL/min/1.73 m2; Case: eGFR< 90 mL/min/1.73 m2; Data were presented as the mean ± standard deviation for normal or similar normal distributed variables, number (percentage) for categorical variables, or median (25th,75th percentiles) for variables having skewed distribution. The comparison of normally distributed variables between cases and controls was tested by t tests, and skewed distributed variables were tested by Mann–Whitney U tests
  2. Abbreviation: BMI body mass index, DBP diastolic blood pressure, SBP systolic blood pressure, FPG fasting plasma glucose, HbA1c glycosylated hemoglobin, TG triglyceride, TC cholestenone, HDL high-density lipoprotein, LDL low-density lipoprotein, hs-CRP hypersensitive C-reactive protein, UA uric acid, BUN blood urea nitrogen, SG specific gravity, CA211 carbohydrate antigen 211, CEA carcinoembryonic antigen, SCC squamous cell carcinoma, TT3 total triiodothyronine